Overall, analysis of published expression and survival data obtained from patients with non-small cell lung cancer and lung adenocarcinoma39 showed that low CH25H expression was associated with poor prognosis in these patients (Fig. 2b, Supplementary Fig. 2b). The gene discussed is CH25H; the disease is non-small cell lung carcinoma.